Nitrosamine

MEGGLE introduced an interactive, science-based tool designed to help you assess nitrosamine formation risk and optimize acceptable nitrite limits in...

Understanding the Risks Associated with Nitrosamines Nitrosamines have become a major concern in the pharmaceutical industry since their detection in...

Abstract The recovery of solvents in pharmaceutical manufacturing offers substantial sustainability benefits but raises concerns about the potential carryover of...

Abstract Atmospheric nitrogen oxides (NOx) have emerged as a potential contributor to nitrosamine formation in active pharmaceutical ingredients (APIs) containing...

Abstract This work presents a method optimization strategy for determining nitrite ions in pharmaceutical excipients. After derivatization, nitrite ions were...

Abstract Rigorous control of N-nitrosamine impurities within drug products is essential due to their potential carcinogenicity. Nitrosamines are often formed through...

Abstract Between 2018 and 2021, losartan was the most often recalled product (24% of total recalls) followed by metformin tablets...

Join our inspiring expert talk on nitrites/nitrosamines:  Description: Since 2018, nitrosamines have gone from an unexpected impurity issue to a...

Abstract Following the discovery of N-nitrosamines in a range of medicinal products, regulatory agencies have required marketing authorization holders to undertake...

Frankfurt, Germany, 02 October, 2024 The future of excipients is here: Meet DFE Pharma at CPHI DFE Pharma invites you to...